img

Global PD-1 and PD-L1 Monoclonal Antibody Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global PD-1 and PD-L1 Monoclonal Antibody Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

PD-1 and PD-L1 Monoclonal Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PD-1 and PD-L1 Monoclonal Antibody market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Lung Cancer and Liver Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for PD-1 and PD-L1 Monoclonal Antibody industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, PD-1 and PD-L1 Monoclonal Antibody key manufacturers include Merk, Bristol-Myers Squibb Company, Roche, Pfizer, AstraZeneca, Junshi Biosciences, Innovent, Hengrui and BeiGene, etc. Merk, Bristol-Myers Squibb Company, Roche are top 3 players and held % sales share in total in 2022.
PD-1 and PD-L1 Monoclonal Antibody can be divided into PD-1 and PD-L1, etc. PD-1 is the mainstream product in the market, accounting for % sales share globally in 2022.
PD-1 and PD-L1 Monoclonal Antibody is widely used in various fields, such as Lung Cancer, Liver Cancer, Esophageal Cancer and Gastric Cancer, etc. Lung Cancer provides greatest supports to the PD-1 and PD-L1 Monoclonal Antibody industry development. In 2022, global % sales of PD-1 and PD-L1 Monoclonal Antibody went into Lung Cancer filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global PD-1 and PD-L1 Monoclonal Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merk
Bristol-Myers Squibb Company
Roche
Pfizer
AstraZeneca
Junshi Biosciences
Innovent
Hengrui
BeiGene
Alphamab Oncology
Cstone
Akeso
Segment by Type
PD-1
PD-L1

Segment by Application


Lung Cancer
Liver Cancer
Esophageal Cancer
Gastric Cancer
Nasopharyngeal Carcinoma
Head and Neck Cancer
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the PD-1 and PD-L1 Monoclonal Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of PD-1 and PD-L1 Monoclonal Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the PD-1 and PD-L1 Monoclonal Antibody industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of PD-1 and PD-L1 Monoclonal Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, PD-1 and PD-L1 Monoclonal Antibody introduction, etc. PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of PD-1 and PD-L1 Monoclonal Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 PD-1 and PD-L1 Monoclonal Antibody Market Overview
1.1 PD-1 and PD-L1 Monoclonal Antibody Product Overview
1.2 PD-1 and PD-L1 Monoclonal Antibody Market Segment by Type
1.2.1 PD-1
1.2.2 PD-L1
1.3 Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Type
1.3.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size Overview by Type (2024-2034)
1.3.2 Global PD-1 and PD-L1 Monoclonal Antibody Historic Market Size Review by Type (2024-2024)
1.3.3 Global PD-1 and PD-L1 Monoclonal Antibody Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales Breakdown by Type (2024-2024)
1.4.2 Europe PD-1 and PD-L1 Monoclonal Antibody Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Breakdown by Type (2024-2024)
1.4.4 Latin America PD-1 and PD-L1 Monoclonal Antibody Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales Breakdown by Type (2024-2024)
2 Global PD-1 and PD-L1 Monoclonal Antibody Market Competition by Company
2.1 Global Top Players by PD-1 and PD-L1 Monoclonal Antibody Sales (2024-2024)
2.2 Global Top Players by PD-1 and PD-L1 Monoclonal Antibody Revenue (2024-2024)
2.3 Global Top Players by PD-1 and PD-L1 Monoclonal Antibody Price (2024-2024)
2.4 Global Top Manufacturers PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 PD-1 and PD-L1 Monoclonal Antibody Market Competitive Situation and Trends
2.5.1 PD-1 and PD-L1 Monoclonal Antibody Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Monoclonal Antibody as of 2022)
2.7 Date of Key Manufacturers Enter into PD-1 and PD-L1 Monoclonal Antibody Market
2.8 Key Manufacturers PD-1 and PD-L1 Monoclonal Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion
3 PD-1 and PD-L1 Monoclonal Antibody Status and Outlook by Region
3.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global PD-1 and PD-L1 Monoclonal Antibody Historic Market Size by Region
3.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Region (2024-2024)
3.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Value by Region (2024-2024)
3.2.3 Global PD-1 and PD-L1 Monoclonal Antibody Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global PD-1 and PD-L1 Monoclonal Antibody Forecasted Market Size by Region
3.3.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Region (2024-2034)
3.3.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales in Value by Region (2024-2034)
3.3.3 Global PD-1 and PD-L1 Monoclonal Antibody Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global PD-1 and PD-L1 Monoclonal Antibody by Application
4.1 PD-1 and PD-L1 Monoclonal Antibody Market Segment by Application
4.1.1 Lung Cancer
4.1.2 Liver Cancer
4.1.3 Esophageal Cancer
4.1.4 Gastric Cancer
4.1.5 Nasopharyngeal Carcinoma
4.1.6 Head and Neck Cancer
4.1.7 Other
4.2 Global PD-1 and PD-L1 Monoclonal Antibody Market Size by Application
4.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size Overview by Application (2024-2034)
4.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Historic Market Size Review by Application (2024-2024)
4.2.3 Global PD-1 and PD-L1 Monoclonal Antibody Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales Breakdown by Application (2024-2024)
4.3.2 Europe PD-1 and PD-L1 Monoclonal Antibody Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Breakdown by Application (2024-2024)
4.3.4 Latin America PD-1 and PD-L1 Monoclonal Antibody Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales Breakdown by Application (2024-2024)
5 North America PD-1 and PD-L1 Monoclonal Antibody by Country
5.1 North America PD-1 and PD-L1 Monoclonal Antibody Historic Market Size by Country
5.1.1 North America PD-1 and PD-L1 Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2024-2024)
5.1.3 North America PD-1 and PD-L1 Monoclonal Antibody Sales in Value by Country (2024-2024)
5.2 North America PD-1 and PD-L1 Monoclonal Antibody Forecasted Market Size by Country
5.2.1 North America PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2024-2034)
5.2.2 North America PD-1 and PD-L1 Monoclonal Antibody Sales in Value by Country (2024-2034)
6 Europe PD-1 and PD-L1 Monoclonal Antibody by Country
6.1 Europe PD-1 and PD-L1 Monoclonal Antibody Historic Market Size by Country
6.1.1 Europe PD-1 and PD-L1 Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2024-2024)
6.1.3 Europe PD-1 and PD-L1 Monoclonal Antibody Sales in Value by Country (2024-2024)
6.2 Europe PD-1 and PD-L1 Monoclonal Antibody Forecasted Market Size by Country
6.2.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2024-2034)
6.2.2 Europe PD-1 and PD-L1 Monoclonal Antibody Sales in Value by Country (2024-2034)
7 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody by Region
7.1 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Historic Market Size by Region
7.1.1 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales in Value by Region (2024-2024)
7.2 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales in Value by Region (2024-2034)
8 Latin America PD-1 and PD-L1 Monoclonal Antibody by Country
8.1 Latin America PD-1 and PD-L1 Monoclonal Antibody Historic Market Size by Country
8.1.1 Latin America PD-1 and PD-L1 Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2024-2024)
8.1.3 Latin America PD-1 and PD-L1 Monoclonal Antibody Sales in Value by Country (2024-2024)
8.2 Latin America PD-1 and PD-L1 Monoclonal Antibody Forecasted Market Size by Country
8.2.1 Latin America PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2024-2034)
8.2.2 Latin America PD-1 and PD-L1 Monoclonal Antibody Sales in Value by Country (2024-2034)
9 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody by Country
9.1 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Historic Market Size by Country
9.1.1 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales in Value by Country (2024-2024)
9.2 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merk
10.1.1 Merk Company Information
10.1.2 Merk Introduction and Business Overview
10.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Merk PD-1 and PD-L1 Monoclonal Antibody Products Offered
10.1.5 Merk Recent Development
10.2 Bristol-Myers Squibb Company
10.2.1 Bristol-Myers Squibb Company Company Information
10.2.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Products Offered
10.2.5 Bristol-Myers Squibb Company Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Roche PD-1 and PD-L1 Monoclonal Antibody Products Offered
10.3.5 Roche Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Pfizer PD-1 and PD-L1 Monoclonal Antibody Products Offered
10.4.5 Pfizer Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.5.4 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Junshi Biosciences
10.6.1 Junshi Biosciences Company Information
10.6.2 Junshi Biosciences Introduction and Business Overview
10.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Products Offered
10.6.5 Junshi Biosciences Recent Development
10.7 Innovent
10.7.1 Innovent Company Information
10.7.2 Innovent Introduction and Business Overview
10.7.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Innovent PD-1 and PD-L1 Monoclonal Antibody Products Offered
10.7.5 Innovent Recent Development
10.8 Hengrui
10.8.1 Hengrui Company Information
10.8.2 Hengrui Introduction and Business Overview
10.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Hengrui PD-1 and PD-L1 Monoclonal Antibody Products Offered
10.8.5 Hengrui Recent Development
10.9 BeiGene
10.9.1 BeiGene Company Information
10.9.2 BeiGene Introduction and Business Overview
10.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.9.4 BeiGene PD-1 and PD-L1 Monoclonal Antibody Products Offered
10.9.5 BeiGene Recent Development
10.10 Alphamab Oncology
10.10.1 Alphamab Oncology Company Information
10.10.2 Alphamab Oncology Introduction and Business Overview
10.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Products Offered
10.10.5 Alphamab Oncology Recent Development
10.11 Cstone
10.11.1 Cstone Company Information
10.11.2 Cstone Introduction and Business Overview
10.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Cstone PD-1 and PD-L1 Monoclonal Antibody Products Offered
10.11.5 Cstone Recent Development
10.12 Akeso
10.12.1 Akeso Company Information
10.12.2 Akeso Introduction and Business Overview
10.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Akeso PD-1 and PD-L1 Monoclonal Antibody Products Offered
10.12.5 Akeso Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 PD-1 and PD-L1 Monoclonal Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 PD-1 and PD-L1 Monoclonal Antibody Industrial Chain Analysis
11.4 PD-1 and PD-L1 Monoclonal Antibody Market Dynamics
11.4.1 PD-1 and PD-L1 Monoclonal Antibody Industry Trends
11.4.2 PD-1 and PD-L1 Monoclonal Antibody Market Drivers
11.4.3 PD-1 and PD-L1 Monoclonal Antibody Market Challenges
11.4.4 PD-1 and PD-L1 Monoclonal Antibody Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 PD-1 and PD-L1 Monoclonal Antibody Distributors
12.3 PD-1 and PD-L1 Monoclonal Antibody Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of PD-1
Table 2. Major Company of PD-L1
Table 3. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2024-2024) & (Units)
Table 5. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Type (2024-2024)
Table 6. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2024-2024) & (US& Million)
Table 7. Global PD-1 and PD-L1 Monoclonal Antibody Market Share in Value by Type (2024-2024)
Table 8. Global PD-1 and PD-L1 Monoclonal Antibody Price by Type (2024-2024) & (US$/Unit)
Table 9. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2024-2034) & (Units)
Table 10. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Type (2024-2034)
Table 11. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2024-2034) & (US$ Million)
Table 12. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Type (2024-2034)
Table 13. Global PD-1 and PD-L1 Monoclonal Antibody Price by Type (2024-2034) & (US$/Unit)
Table 14. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2024-2024) & (Units)
Table 15. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe PD-1 and PD-L1 Monoclonal Antibody Sales (Units) by Type (2024-2024)
Table 17. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales (Units) by Type (2024-2024)
Table 19. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales (Units) by Type (2024-2024)
Table 21. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales (Units) by Type (2024-2024)
Table 23. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 24. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Company (2024-2024) & (Units)
Table 25. Global PD-1 and PD-L1 Monoclonal Antibody Sales Share by Company (2024-2024)
Table 26. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Company (2024-2024)
Table 28. Global Market PD-1 and PD-L1 Monoclonal Antibody Price by Company (2024-2024) & (US$/Unit)
Table 29. Global PD-1 and PD-L1 Monoclonal Antibody Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global PD-1 and PD-L1 Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Monoclonal Antibody as of 2022)
Table 32. Date of Key Manufacturers Enter into PD-1 and PD-L1 Monoclonal Antibody Market
Table 33. Key Manufacturers PD-1 and PD-L1 Monoclonal Antibody Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global PD-1 and PD-L1 Monoclonal Antibody Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2024-2024) & (Units)
Table 37. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Region (2024-2024)
Table 38. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2024-2024) & (US$ Million)
Table 39. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Region (2024-2024)
Table 40. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2024-2034) & (Units)
Table 42. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Region (2024-2034)
Table 43. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2024-2034) & (US$ Million)
Table 44. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Region (2024-2034)
Table 45. Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2024) & (Units)
Table 48. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Application (2024-2024)
Table 49. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 50. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Application (2024-2024)
Table 51. Global PD-1 and PD-L1 Monoclonal Antibody Price by Application (2024-2024) & (US$/Unit)
Table 52. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2034) & (Units)
Table 53. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Application (2024-2034)
Table 54. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2034) & (US$ Million)
Table 55. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Application (2024-2034)
Table 56. Global PD-1 and PD-L1 Monoclonal Antibody Price by Application (2024-2034) & (US$/Unit)
Table 57. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2024) (Units)
Table 58. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2024) (Units)
Table 60. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2024) (Units)
Table 62. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2024) (Units)
Table 64. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2024) (Units)
Table 66. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 67. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2024) & (Units)
Table 68. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Country (2024-2024)
Table 69. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2024) & (US$ Million)
Table 70. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Country (2024-2024)
Table 71. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2034) & (Units)
Table 72. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Country (2024-2034)
Table 73. North America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2034) & (US$ Million)
Table 74. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Country (2024-2034)
Table 75. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2024) & (Units)
Table 76. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Country (2024-2024)
Table 79. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2034) & (Units)
Table 80. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2024-2024) & (Units)
Table 84. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2024-2034) & (Units)
Table 88. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2024) & (Units)
Table 92. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2034) & (Units)
Table 96. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2024) & (Units)
Table 100. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2034) & (Units)
Table 104. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Country (2024-2034)
Table 107. Merk Company Information
Table 108. Merk Introduction and Business Overview
Table 109. Merk PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Merk PD-1 and PD-L1 Monoclonal Antibody Product
Table 111. Merk Recent Development
Table 112. Bristol-Myers Squibb Company Company Information
Table 113. Bristol-Myers Squibb Company Introduction and Business Overview
Table 114. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product
Table 116. Bristol-Myers Squibb Company Recent Development
Table 117. Roche Company Information
Table 118. Roche Introduction and Business Overview
Table 119. Roche PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Roche PD-1 and PD-L1 Monoclonal Antibody Product
Table 121. Roche Recent Development
Table 122. Pfizer Company Information
Table 123. Pfizer Introduction and Business Overview
Table 124. Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Pfizer PD-1 and PD-L1 Monoclonal Antibody Product
Table 126. Pfizer Recent Development
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Introduction and Business Overview
Table 129. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product
Table 131. AstraZeneca Recent Development
Table 132. Junshi Biosciences Company Information
Table 133. Junshi Biosciences Introduction and Business Overview
Table 134. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product
Table 136. Junshi Biosciences Recent Development
Table 137. Innovent Company Information
Table 138. Innovent Introduction and Business Overview
Table 139. Innovent PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Innovent PD-1 and PD-L1 Monoclonal Antibody Product
Table 141. Innovent Recent Development
Table 142. Hengrui Company Information
Table 143. Hengrui Introduction and Business Overview
Table 144. Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Hengrui PD-1 and PD-L1 Monoclonal Antibody Product
Table 146. Hengrui Recent Development
Table 147. BeiGene Company Information
Table 148. BeiGene Introduction and Business Overview
Table 149. BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. BeiGene PD-1 and PD-L1 Monoclonal Antibody Product
Table 151. BeiGene Recent Development
Table 152. Alphamab Oncology Company Information
Table 153. Alphamab Oncology Introduction and Business Overview
Table 154. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product
Table 156. Alphamab Oncology Recent Development
Table 157. Cstone Company Information
Table 158. Cstone Introduction and Business Overview
Table 159. Cstone PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Cstone PD-1 and PD-L1 Monoclonal Antibody Product
Table 161. Cstone Recent Development
Table 162. Akeso Company Information
Table 163. Akeso Introduction and Business Overview
Table 164. Akeso PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Akeso PD-1 and PD-L1 Monoclonal Antibody Product
Table 166. Akeso Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. PD-1 and PD-L1 Monoclonal Antibody Market Trends
Table 170. PD-1 and PD-L1 Monoclonal Antibody Market Drivers
Table 171. PD-1 and PD-L1 Monoclonal Antibody Market Challenges
Table 172. PD-1 and PD-L1 Monoclonal Antibody Market Restraints
Table 173. PD-1 and PD-L1 Monoclonal Antibody Distributors List
Table 174. PD-1 and PD-L1 Monoclonal Antibody Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. PD-1 and PD-L1 Monoclonal Antibody Product Picture
Figure 2. Global PD-1 and PD-L1 Monoclonal Antibody Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global PD-1 and PD-L1 Monoclonal Antibody Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global PD-1 and PD-L1 Monoclonal Antibody Sales Status and Outlook (2024-2034) & (Units)
Figure 5. Product Picture of PD-1
Figure 6. Global PD-1 Sales YoY Growth (2024-2034) & (Units)
Figure 7. Product Picture of PD-L1
Figure 8. Global PD-L1 Sales YoY Growth (2024-2034) & (Units)
Figure 9. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type in 2022 & 2034
Figure 11. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 12. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 13. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 14. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 17. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 18. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by PD-1 and PD-L1 Monoclonal Antibody Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by PD-1 and PD-L1 Monoclonal Antibody Revenue in 2022
Figure 23. PD-1 and PD-L1 Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Lung Cancer
Figure 25. Global Lung Cancer Sales YoY Growth (2024-2034) & (Units)
Figure 26. Product Picture of Liver Cancer
Figure 27. Global Liver Cancer Sales YoY Growth (2024-2034) & (Units)
Figure 28. Product Picture of Esophageal Cancer
Figure 29. Global Esophageal Cancer Sales YoY Growth (2024-2034) & (Units)
Figure 30. Product Picture of Gastric Cancer
Figure 31. Global Gastric Cancer Sales YoY Growth (2024-2034) & (Units)
Figure 32. Product Picture of Nasopharyngeal Carcinoma
Figure 33. Global Nasopharyngeal Carcinoma Sales YoY Growth (2024-2034) & (Units)
Figure 34. Product Picture of Head and Neck Cancer
Figure 35. Global Head and Neck Cancer Sales YoY Growth (2024-2034) & (Units)
Figure 36. Product Picture of Other
Figure 37. Global Other Sales YoY Growth (2024-2034) & (Units)
Figure 38. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application in 2022 & 2034
Figure 40. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Application in 2022
Figure 41. North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 42. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Application in 2022
Figure 43. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 46. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Volume by Application in 2022
Figure 47. Latin America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. PD-1 and PD-L1 Monoclonal Antibody Manufacturing Cost Structure
Figure 51. PD-1 and PD-L1 Monoclonal Antibody Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries